Trump’s Drug-Pricing Push Delivers Some Discounts, But Prices Climb for Many
TL;DR Summary
Trump’s drug-pricing efforts have yielded uneven gains: Medicare's negotiated discounts cut some prices and cap out-of-pocket costs, and TrumpRx offered notable cuts on certain brand drugs, but overall about 1,000 branded drugs rose in price in early 2026, and benefits mostly reach cash-paying patients, with many discounts opaque and limited in scope; experts say the policy changes do not broadly reshape drug pricing.
- Trump promised cheaper drugs. Some prices dropped. Many others shot up. CBS News
- White House touts $529B in MFN savings over 10 years Fierce Pharma
- 'That alone should win us the midterms': Trump wants voters to ignore higher costs, giant pharma profits and focus on drug prices Fortune
- Drug pricing deal to generate savings of $64.3 billion over 10 years, White House says Reuters
- Administration report on most favored nation drug pricing raises new details — and questions statnews.com
Reading Insights
Total Reads
0
Unique Readers
8
Time Saved
9 min
vs 10 min read
Condensed
97%
1,940 → 63 words
Want the full story? Read the original article
Read on CBS News